Simplex Trading’s Syros Pharmaceuticals, Inc. Common Stock SYRS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-4,123
| Closed | – | – | 10022 |
|
|
2025
Q1 | $0 | Buy |
+4,123
| New | +$695 | ﹤0.01% | 9971 |
|
|
2024
Q3 | – | Sell |
-14,091
| Closed | -$50.6K | – | 9817 |
|
|
2024
Q2 | $72K | Buy |
14,091
+13,859
| +5,974% | +$72.8K | ﹤0.01% | 5718 |
|
|
2024
Q1 | $1K | Buy |
+232
| New | +$1.6K | ﹤0.01% | 8683 |
|
|
2023
Q2 | – | Sell |
-196
| Closed | -$630 | – | 10164 |
|
|
2023
Q1 | $0 | Sell |
196
-1,093
| -85% | -$4.24K | ﹤0.01% | 10361 |
|
|
2022
Q4 | $4K | Buy |
+1,289
| New | +$5.59K | ﹤0.01% | 8287 |
|
|
2022
Q3 | – | Sell |
-14
| Closed | -$114 | – | 11092 |
|
|
2022
Q2 | $0 | Buy |
+14
| New | +$131 | ﹤0.01% | 11347 |
|
|
2022
Q1 | – | Sell |
-39
| Closed | -$698 | – | 11593 |
|
|
2021
Q4 | $1K | Sell |
39
-4,473
| -99% | -$181K | ﹤0.01% | 10279 |
|
|
2021
Q3 | $255K | Sell |
4,512
-24
| -0.5% | -$1.17K | ﹤0.01% | 5193 |
|
|
2021
Q2 | $247K | Buy |
4,536
+2,231
| +97% | +$132K | ﹤0.01% | 5330 |
|
|
2021
Q1 | $172K | Buy |
2,305
+2,064
| +856% | +$214K | ﹤0.01% | 4980 |
|
|
2020
Q4 | $26K | Buy |
241
+232
| +2,578% | +$21.2K | ﹤0.01% | 6802 |
|
|
2020
Q3 | $0 | Buy |
+9
| New | +$1.02K | ﹤0.01% | 8693 |
|
|
2019
Q4 | – | Sell |
-58
| Closed | -$3.52K | – | 8104 |
|
|
2019
Q3 | $6K | Sell |
58
-13
| -18% | -$1.23K | ﹤0.01% | 6554 |
|
|
2019
Q2 | $6K | Buy |
71
+19
| +37% | +$1.32K | ﹤0.01% | 6390 |
|
|
2019
Q1 | $4K | Sell |
52
-55
| -51% | -$3.83K | ﹤0.01% | 6594 |
|
|
2018
Q4 | $5K | Sell |
107
-49
| -31% | -$3.72K | ﹤0.01% | 6248 |
|
|
2018
Q3 | $18K | Buy |
156
+63
| +68% | +$7.31K | ﹤0.01% | 6050 |
|
|
2018
Q2 | $9K | Sell |
93
-152
| -62% | -$18.8K | ﹤0.01% | 6421 |
|
|
2018
Q1 | $31K | Sell |
245
-939
| -79% | -$103K | ﹤0.01% | 2919 |
|
|
2017
Q4 | $115K | Buy |
+1,184
| New | +$159K | ﹤0.01% | 1693 |
|
Simplex Trading's SYRS Position: Q2 2025 in Review
Simplex Trading sold out of Syros Pharmaceuticals, Inc. Common Stock (SYRS) in Q2 2025, closing a stake of 4,123 shares.
Simplex Trading first reported a position in SYRS in Q4 2017 and held it in 20 quarters. The position peaked at $255K in Q3 2021. 0 funds tracked by Wall St. Rank hold SYRS as of Q2 2025.
- Simplex Trading reported no remaining Syros Pharmaceuticals, Inc. Common Stock position as of Q2 2025 after selling out during the quarter.
- Simplex Trading sold 4,123 Syros Pharmaceuticals, Inc. Common Stock shares in Q2 2025.
- Simplex Trading first reported a position in Syros Pharmaceuticals, Inc. Common Stock in Q4 2017 and held it in 20 quarters.
- Simplex Trading's Syros Pharmaceuticals, Inc. Common Stock position peaked at $255K in Q3 2021.
- 0 funds tracked by Wall St. Rank held Syros Pharmaceuticals, Inc. Common Stock as of Q2 2025.
Based on Simplex Trading's 13F filing for Q2 2025, filed 5 Aug 2025.